About us
Learn how GA4GH helps expand responsible genomic data use to benefit human health.
Learn how GA4GH helps expand responsible genomic data use to benefit human health.
Our Strategic Road Map defines strategies, standards, and policy frameworks to support responsible global use of genomic and related health data.
Discover how a meeting of 50 leaders in genomics and medicine led to an alliance uniting more than 5,000 individuals and organisations to benefit human health.
GA4GH Inc. is a not-for-profit organisation that supports the global GA4GH community.
The GA4GH Council, consisting of the Executive Committee, Strategic Leadership Committee, and Product Steering Committee, guides our collaborative, globe-spanning alliance.
The Funders Forum brings together organisations that offer both financial support and strategic guidance.
The EDI Advisory Group responds to issues raised in the GA4GH community, finding equitable, inclusive ways to build products that benefit diverse groups.
Distributed across a number of Host Institutions, our staff team supports the mission and operations of GA4GH.
Curious who we are? Meet the people and organisations across six continents who make up GA4GH.
More than 500 organisations connected to genomics — in healthcare, research, patient advocacy, industry, and beyond — have signed onto the mission and vision of GA4GH as Organisational Members.
These core Organisational Members are genomic data initiatives that have committed resources to guide GA4GH work and pilot our products.
This subset of Organisational Members whose networks or infrastructure align with GA4GH priorities has made a long-term commitment to engaging with our community.
Local and national organisations assign experts to spend at least 30% of their time building GA4GH products.
Anyone working in genomics and related fields is invited to participate in our inclusive community by creating and using new products.
Wondering what GA4GH does? Learn how we find and overcome challenges to expanding responsible genomic data use for the benefit of human health.
Study Groups define needs. Participants survey the landscape of the genomics and health community and determine whether GA4GH can help.
Work Streams create products. Community members join together to develop technical standards, policy frameworks, and policy tools that overcome hurdles to international genomic data use.
GIF solves problems. Organisations in the forum pilot GA4GH products in real-world situations. Along the way, they troubleshoot products, suggest updates, and flag additional needs.
NIF finds challenges and opportunities in genomics at a global scale. National programmes meet to share best practices, avoid incompatabilities, and help translate genomics into benefits for human health.
Communities of Interest find challenges and opportunities in areas such as rare disease, cancer, and infectious disease. Participants pinpoint real-world problems that would benefit from broad data use.
Find out what’s happening with up to the minute meeting schedules for the GA4GH community.
See all our products — always free and open-source. Do you work on cloud genomics, data discovery, user access, data security or regulatory policy and ethics? Need to represent genomic, phenotypic, or clinical data? We’ve got a solution for you.
All GA4GH standards, frameworks, and tools follow the Product Development and Approval Process before being officially adopted.
Learn how other organisations have implemented GA4GH products to solve real-world problems.
Help us transform the future of genomic data use! See how GA4GH can benefit you — whether you’re using our products, writing our standards, subscribing to a newsletter, or more.
Help create new global standards and frameworks for responsible genomic data use.
Align your organisation with the GA4GH mission and vision.
Want to advance both your career and responsible genomic data sharing at the same time? See our open leadership opportunities.
Join our international team and help us advance genomic data use for the benefit of human health.
Share your thoughts on all GA4GH products currently open for public comment.
Solve real problems by aligning your organisation with the world’s genomics standards. We offer software dvelopers both customisable and out-of-the-box solutions to help you get started.
Learn more about upcoming GA4GH events. See reports and recordings from our past events.
Speak directly to the global genomics and health community while supporting GA4GH strategy.
Be the first to hear about the latest GA4GH products, upcoming meetings, new initiatives, and more.
Questions? We would love to hear from you.
Read news, stories, and insights from the forefront of genomic and clinical data use.
Attend an upcoming GA4GH event, or view meeting reports from past events.
See new projects, updates, and calls for support from the Work Streams.
Read academic papers coauthored by GA4GH contributors.
Listen to our podcast OmicsXchange, featuring discussions from leaders in the world of genomics, health, and data sharing.
Check out our videos, then subscribe to our YouTube channel for more content.
View the latest GA4GH updates, Genomics and Health News, Implementation Notes, GDPR Briefs, and more.
Discover all things GA4GH: explore our news, events, videos, podcasts, announcements, publications, and newsletters.
9 Aug 2021
GA4GH has received funding from the Canadian Institutes of Health Research (CIHR) in order to advance data sharing tools in the fight against COVID-19.
GA4GH has received funding from the Canadian Institutes of Health Research (CIHR) in order to advance data sharing tools in the fight against COVID-19.
As the federal funding agency for health research, CIHR has been vital to Canada’s COVID-19 response—contributing almost $250 million to support more than 400 COVID-19 research projects across the country, including a major effort to survey, sequence, trace, and research variants of concern identified in Canada through the Coronavirus Variants Rapid Response Network (CoVaRR-Net). CIHR has also partnered with organizations such as the World Health Organization (WHO) and the Global Research Collaboration for Infectious Disease Preparedness to ensure alignment and coordination at a global level.
“Canadian funding agencies have been critical to the work of GA4GH since 2014,” said Peter Goodhand, Chief Executive Officer of GA4GH. “Through CIHR’s funding, we hope to strengthen international standards in order to more effectively respond to current developments and future outbreaks.”
With the new funding support, GA4GH aims to further link Canada’s research efforts to the international data sharing ecosystem via interoperable technical standards and policy frameworks. As the grant recipient, the Ontario Institute for Cancer Research (OICR)—which also serves as a GA4GH Host Institution—will serve as an active collaborator alongside several Canadian partners:CoVaRR-Net, the Digital Supercluster COVID Cloud, and the Canadian COVID-19 Genomics Network (CanCOGeN) VirusSeq and HostSeq portals. Together, they will aim to advance and support uptake of GA4GH standards within the Canadian COVID-19 research community.
In addition, GA4GH international partners such as the Public Health Alliance for Genomic Epidemiology (PHA4GE), the International COVID-19 Data Alliance (ICODA), the COVID-19 Host Genetics Initiative, and the COVID-19 Genomics UK (COG-UK) consortium will help ensure that Canadian efforts are connected—both technically and strategically—to the broader international community.
Strengthening these relationships will support findable, accessible, interoperable, and reproducible (FAIR) data and open science and will help enable the rapid and timely research response to new variants of concern in Canada and around the globe.
The funding will be used to:
Additionally, the GA4GH Regulatory and Ethics Work Stream (REWS) and the GA4GH Equity, Diversity, and Inclusion (EDI) advisory group will work with Pillar 7 of CoVarr-Net, which focuses on CIEDAR (COVID-19 Indigenous Engagement, Development, and Research) to identify specific concerns related to Indigenous populations when it comes to sharing data and developing responsible standards and tools. This relationship, as well as additional input from the community, will help REWS develop guidance on engaging marginalized/vulnerable communities to foster better pandemic data sharing based on the opportunities and hurdles of the Canadian and international COVID-19 experience.